These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16539660

  • 1. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.
    Contestabile A, Fila T, Bartesaghi R, Contestabile A, Ciani E.
    J Neurochem; 2006 Apr; 97(2):515-26. PubMed ID: 16539660
    [Abstract] [Full Text] [Related]

  • 2. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
    Seo H, Isacson O.
    Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP.
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [Abstract] [Full Text] [Related]

  • 4. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
    Hyde LA, Crnic LS.
    Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055
    [Abstract] [Full Text] [Related]

  • 5. The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice.
    Kalesnykas G, Roschier U, Puoliväli J, Wang J, Miettinen R.
    Eur J Neurosci; 2005 Mar; 21(5):1437-42. PubMed ID: 15813954
    [Abstract] [Full Text] [Related]

  • 6. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC, Sanders LA, Crnic LS.
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [Abstract] [Full Text] [Related]

  • 7. Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice.
    Wang F, Chen H, Sun X.
    Neurosci Lett; 2009 May 01; 454(3):212-7. PubMed ID: 19429086
    [Abstract] [Full Text] [Related]

  • 8. Changes in brain cholinergic markers and spatial learning in old galanin-overexpressing mice.
    Pirondi S, D'Intino G, Gusciglio M, Massella A, Giardino L, Kuteeva E, Ogren SO, Hökfelt T, Calzà L.
    Brain Res; 2007 Mar 23; 1138():10-20. PubMed ID: 17266943
    [Abstract] [Full Text] [Related]

  • 9. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM, Ash JA, Powers BE, Velazquez R, Alldred MJ, Ikonomovic MD, Ginsberg SD, Strupp BJ, Mufson EJ.
    Curr Alzheimer Res; 2016 Mar 23; 13(1):84-96. PubMed ID: 26391045
    [Abstract] [Full Text] [Related]

  • 10. A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome.
    Lane NJ, Balbo A, Rapoport SI.
    Cell Biol Int; 1996 Oct 23; 20(10):673-80. PubMed ID: 8969460
    [Abstract] [Full Text] [Related]

  • 11. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats.
    Ricceri L, Minghetti L, Moles A, Popoli P, Confaloni A, De Simone R, Piscopo P, Scattoni ML, di Luca M, Calamandrei G.
    Exp Neurol; 2004 Sep 23; 189(1):162-72. PubMed ID: 15296846
    [Abstract] [Full Text] [Related]

  • 12. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.
    Lorenzi HA, Reeves RH.
    Brain Res; 2006 Aug 09; 1104(1):153-9. PubMed ID: 16828061
    [Abstract] [Full Text] [Related]

  • 13. Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus.
    Varga C, Härtig W, Grosche J, Keijser J, Luiten PG, Seeger J, Brauer K, Harkany T.
    J Comp Neurol; 2003 Jun 09; 460(4):597-611. PubMed ID: 12717717
    [Abstract] [Full Text] [Related]

  • 14. [Effects of Chinese herb compound Naoyikang on expression of choline acetyltransferase in brain of rats with Alzheimer's disease].
    Geng JS, Zhou AL, Shi HY, Hu YE, Mao JH, Zhu Y.
    Zhongguo Zhong Yao Za Zhi; 2008 May 09; 33(9):1071-4. PubMed ID: 18652361
    [Abstract] [Full Text] [Related]

  • 15. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M, Heckers S, Mash DC, Geula C, Mesulam MM.
    J Comp Neurol; 1993 Oct 01; 336(1):117-34. PubMed ID: 8254109
    [Abstract] [Full Text] [Related]

  • 16. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC.
    Neuron; 2006 Jul 06; 51(1):29-42. PubMed ID: 16815330
    [Abstract] [Full Text] [Related]

  • 17. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J.
    Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170
    [Abstract] [Full Text] [Related]

  • 18. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.
    Ikonomovic MD, Mufson EJ, Wuu J, Bennett DA, DeKosky ST.
    Arch Neurol; 2005 Mar 28; 62(3):425-30. PubMed ID: 15767507
    [Abstract] [Full Text] [Related]

  • 19. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
    Chen Y, Dyakin VV, Branch CA, Ardekani B, Yang D, Guilfoyle DN, Peterson J, Peterhoff C, Ginsberg SD, Cataldo AM, Nixon RA.
    Neurobiol Aging; 2009 Sep 28; 30(9):1453-65. PubMed ID: 18180075
    [Abstract] [Full Text] [Related]

  • 20. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK, Kelley CM, Lee SH, Alldred MJ, McDaid J, Mufson EJ, Stutzmann GE, Ginsberg SD.
    Neurobiol Dis; 2023 Nov 28; 188():106332. PubMed ID: 37890559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.